SB

Shanti Bhushan Rao

Active Director Director DIN 01818149
DIN 01818149 First appointment Oct 2004 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2004
Shareholding value •••• Premium profile

About Shanti Bhushan Rao

Data last updated:

Shanti Bhushan Rao is a Director at Ginsburg Drugs And Formulations Private Limited (since 2004). The company operates in Healthcare. Ginsburg Drugs And Formulations Private Limited reported revenue of ₹1.56 Cr (FY 2024).

DIN 01818149
Primary Designation Director
Industry Healthcare
First Appointment 11 Oct 2004
Oldest Company Age 22 yrs
Largest company Ginsburg Drugs And Formulations Private Limited · ₹1.56 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Oct 20042004₹1.56 Cr (FY 2024)Active

Board colleagues of Shanti Bhushan Rao

Directorship timeline

Open interactive timeline →
Ginsburg Drugs And Formulations Private Limited
Premium access

Shareholding and investment profile for Shanti Bhushan Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shanti Bhushan Rao

Shanti Bhushan Rao currently holds 1 directorship: Ginsburg Drugs And Formulations Private Limited (Director, since 11 Oct 2004, revenue ₹1.56 Cr (FY 2024)).

Shanti Bhushan Rao was first appointed on 11 Oct 2004 as Director at Ginsburg Drugs And Formulations Private Limited.

The current boards of Shanti Bhushan Rao's companies include Avnish Rao (Ginsburg Drugs And Formulations Private Limited), Vasu Vinayak Rao (Ginsburg Drugs And Formulations Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available